Measured Neutralizing Titers of IFN- β Neutralizing Antibodies (NAbs) Can Depend on the Preparations...
Measured Neutralizing Titers of IFN- β Neutralizing Antibodies (NAbs) Can Depend on the Preparations of IFN- β Used in the Assay
About this item
Full title
Author / Creator
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
An immune response to recombinant human protein therapeutics, including type I interferons (IFNs), has the potential to have a serious negative impact on safety and efficacy. Monitoring of patients for neutralizing antibodies (NAbs) often is advisable. In the case of IFN-beta therapy for multiple sclerosis (MS), we obtained reproducible quantitativ...
Alternative Titles
Full title
Measured Neutralizing Titers of IFN- β Neutralizing Antibodies (NAbs) Can Depend on the Preparations of IFN- β Used in the Assay
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_68241169
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_68241169
Other Identifiers
ISSN
1079-9907
E-ISSN
1557-7465
DOI
10.1089/jir.2006.0131
